Evidence map›Paper›PMID 36569030›Full record

ReviewInternational journal of rheumatology2022

Effect of Polymorphisms in the FCN1, FCN2, and FCN3 Genes on the Susceptibility to Develop Rheumatoid Arthritis: A Systematic Review.

Sebastián R Gil-Quiñones, Luz Gutierrez-Castañeda, Lorena Larios-Salazar, Susana Mejia-Mesa, Adriana Motta, David Tovar-Parra

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Advances in the lectin pathway in systemic lupus erythematosus: from clinical correlations and mechanisms to targeted interventions.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sebastián R Gil-QuiñonesUniversidad El Bosque, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-5974-1431
Luz Gutierrez-CastañedaResearch Institute, Basic Science Group, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-6155-3771
Lorena Larios-SalazarOncology Department, BioBayter, PBK1422, Malta.ORCID https://orcid.org/0000-0002-5843-2004
Susana Mejia-MesaUniversidad El Bosque, Bogotá, Colombia.
Adriana MottaDermatology Department, Universidad El Bosque, Bogotá, Colombia.
David Tovar-ParraOncology Department, BioBayter, PBK1422, Malta.ORCID https://orcid.org/0000-0002-1005-4526
Universidad El Bosque · COFundación Universitaria de Ciencias de la Salud · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic association studies in rheumatoid arthritis conducted in various populations have yielded heterogeneous results. The present systematic review was conducted to synthesize the results of the studies in order to establish the impact of polymorphisms in the ficolin-coding genes FCN1, FCN2, and FCN3 on the susceptibility to develop rheumatoid arthritis. A systematic literature review was performed using the following keywords "gene (FCN1/FCN2/FCN3)", "Polymorphism/Genetic Variant", and "rheumatoid arthritis" in different databases until January 2022. Authors assessed articles by title/abstract and then assessed by full text for data extraction. The risk of bias was assessed using the Newcastle-Ottawa scale. Data synthesis was performed qualitatively and quantitatively. A total of 1519 articles were eligible for inclusion in this review, 3 were identified as relevant for the quantitative synthesis with 670 patients and 1019 controls. For the FCN1 gene, an association was found in the dominant and recessive genetic models of the variants rs2989727 (genotype TT = OR: 0.577, 95% CI: 0.430-0.769) and rs1071583 (genotype GG = OR: 1.537, 95% CI: 1.153-2.049,

Identifiers

PMID36569030
PMCPMC9780007
OpenAlexW4311805942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.